在剖腹产期间使用临时心脏起器在患有神经介导的孕妇患者身上:一个病例报告
Shun Takaki1, Fumiya Sawasaki2, Keiko Honma1
1Anesthesiology, Kanazawa Medical University, Uchinada, JPN.
Cureus
|December 22, 2025
概括
本案例研究突出了在接受剖腹产的神经介导 (NMS) 的孕妇中临时起器的成功使用. 起器有效地预防了严重的胸,确保了母亲和新生儿的安全程序.
科学领域:
- 心脏病学 心脏病学
- 产科 产科 产科 产科 产科
- 麻醉学 麻醉学
背景情况:
- 神经介导性 (NMS) 在怀孕期间存在风险,特别是在剖腹产期间.
- 严重的鼻停止史需要在高风险怀孕中仔细的血液动力学管理.
- 结合外围麻醉和脊髓麻醉 (CESA) 可以影响心血管稳定性.
研究的目的:
- 评估临时心脏起器插入在预防NMS患者在剖腹产期间严重的胸肌梗塞的疗效.
- 强调多学科规划对高风险怀孕的重要性.
主要方法:
- 术前插入临时起器 (PM) 在一个39岁的怀孕妇女,有记录的鼻停止.
- 在剖腹产时使用结合外围麻醉和脊柱麻醉 (CESA).
- 用药理学药物 (乙氨酸,氨酸硫酸) 和PM激活的术内监测和治疗心肌梗塞.
主要成果:
- 严重的胸发生在手术期间,触发了PM激活.
- 生命体征迅速稳定了以弗得林和氨酸硫酸盐,PM在两分钟内被停用.
- 剖腹产没有进一步的并发症完成,导致母亲和新生儿的良好结果.
- 术后没有注意到昏迷情节,PM在术后第二天被移除.
结论:
- 在患有NMS的患者中,临时使用心脏起器是在剖腹产期间管理严重心节的有效策略.
- 个性化血液动力学管理和多学科合作对于高风险怀孕的安全分娩至关重要.
相关概念视频
Cardiac Catheterization IV: Nursing Management
602
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
602
Cardiomyopathy VII: Pre and Post Operative Nursing Management
251
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
251
Dysrhythmias VII: Nursing Management of Dysrhythmias
319
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
319
Pulse rhythm
1.3K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.3K
Dysrhythmias VI: Management of Dysrhythmias
385
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
385
Cardiopulmonary Resuscitation IV: Pharmacological Management
570
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
570


